- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 33.43M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $1.42B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.31B |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $86.56M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $33.56M |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $404.82M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $353.62M |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $2.05B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.89B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $975.68M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $822.62M |
| Total Assets | Q1 2025 · Mar 30, 2025 | $3.19B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.02B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 33.12M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $13.01M |
| Capex | Q1 2025 · Mar 31, 2024 | $15.5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $35.18M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.06B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.05B |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $1.06 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $1.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $85.25M |
| Net Income | Q1 2025 · Mar 31, 2024 | $35.09M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $59.34M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $204.86M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $728.64M |
| Revenue | Q1 2025 · Mar 31, 2024 | $933.49M |